Keros Therapeutics Inc (KROS)

12:17 PM

Keros Therapeutics (NASDAQ:KROS) Stock Price Down 3.3%Time to Sell? - MarketBeat

12:17 PM

04:32 AM

Zacks.com featured highlights include AES, BorgWarner, Enersys, PG&E and Keros Therapeutics - Yahoo Finance

04:32 AM

Dec 31, 2025

Short Interest in Keros Therapeutics, Inc. (NASDAQ:KROS) Drops By 16.6% - MarketBeat

Dec 31, 2025

Dec 31, 2025

5 Low Price-to-Book Stocks to Buy as 2025 Comes to a Close - Yahoo Finance

Dec 31, 2025

Dec 30, 2025

KROS or ARGX: Which Is the Better Value Stock Right Now? - sharewise.com

Dec 30, 2025

Dec 29, 2025

Keros Therapeutics Announces Participation at Goldman Sachs 46th Annual Global Healthcare Conference - Quantisnow

Dec 29, 2025

Dec 28, 2025

Keros Therapeutics, Inc. (NASDAQ:KROS) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World

Dec 28, 2025

Dec 28, 2025

Keros Therapeutics, Inc. (NASDAQ:KROS) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Dec 28, 2025

Dec 27, 2025

Keros Therapeutics Stock Plunges 81% in 3 Months: Here's Why - MSN

Dec 27, 2025

Dec 26, 2025

Keros Therapeutics Reports Strong Revenue Growth - MSN

Dec 26, 2025

Dec 23, 2025

Trading the Move, Not the Narrative: (KROS) Edition - Stock Traders Daily

Dec 23, 2025

Dec 23, 2025

Assenagon Asset Management S.A. Has $4.07 Million Holdings in Keros Therapeutics, Inc. $KROS - MarketBeat

Dec 23, 2025

Dec 22, 2025

Keros Therapeutics (KROS) Upgraded to Strong Buy: Here's Why - Yahoo Finance

Dec 22, 2025

Dec 22, 2025

Here's Why Keros Therapeutics (KROS) Could be Great Choice for a Bottom Fisher - Yahoo Finance

Dec 22, 2025

Dec 21, 2025

Keros Therapeutics (NASDAQ:KROS) Raised to “Hold” at TD Cowen - Defense World

Dec 21, 2025

Dec 20, 2025

Keros Therapeutics (NASDAQ:KROS) Upgraded at TD Cowen - MarketBeat

Dec 20, 2025

Dec 19, 2025

Can Keros Therapeutics Inc. stock deliver consistent earnings growthJuly 2025 Chart Watch & Fast Gaining Stock Reports - Улправда

Dec 19, 2025

Dec 19, 2025

How rising interest rates impact Keros Therapeutics Inc. stockJuly 2025 Snapshot & Long-Term Capital Growth Ideas - DonanımHaber

Dec 19, 2025

Dec 18, 2025

Keros Therapeutics (NASDAQ:KROS) Trading Down 3.7%Here's Why - MarketBeat

Dec 18, 2025

Dec 16, 2025

5 High-Risk, High-Reward Biotech Breakthrough Stocks to Watch in 2026 - The Globe and Mail

Dec 16, 2025

Dec 16, 2025

Zacks.com featured highlights include StoneCo, General Motors, Enersys, Deutsche, Keros - sharewise.com

Dec 16, 2025

Dec 15, 2025

Keros Therapeutics Earnings Notes - Trefis

Dec 15, 2025

Dec 13, 2025

TFG Asset Management GP Ltd Sells 55,000 Shares of Keros Therapeutics, Inc. $KROS - MarketBeat

Dec 13, 2025

Dec 13, 2025

Keros Therapeutics commences tender offer to repurchase up to $194.4 million shares - MSN

Dec 13, 2025

Dec 13, 2025

Responsive Playbooks and the KROS Inflection - Stock Traders Daily

Dec 13, 2025

Dec 12, 2025

What Makes Keros Therapeutics, Inc. (KROS) a Strong Momentum Stock: Buy Now? - sharewise.com

Dec 12, 2025

Dec 12, 2025

KROS vs. ARGX: Which Stock Is the Better Value Option? - Yahoo Finance

Dec 12, 2025

Dec 12, 2025

Stocks showing market leadership: Keros Therapeutics earns 92 RS rating - MSN

Dec 12, 2025

Dec 12, 2025

Keros Therapeutics, Inc. $KROS Shares Sold by OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat

Dec 12, 2025

Dec 12, 2025

Keros Therapeutics, Inc. $KROS Stock Holdings Lowered by Federated Hermes Inc. - MarketBeat

Dec 12, 2025

Dec 10, 2025

Aug Summary: How Keros Therapeutics Inc stock performs in interest rate cyclesWeekly Trade Report & Daily Profit Focused Screening - moha.gov.vn

Dec 10, 2025

Dec 09, 2025

Myelofibrosis Market to Expand Significantly by 2034, States DelveInsight Report | Lynk Pharma, Samus Therapeutics, Taiga Biotech, Bristol-Myers Squibb, Sumitomo Pharma Oncology, Keros Therapeutics - Barchart.com

Dec 09, 2025

Dec 07, 2025

Stocks to watch: Keros Therapeutics sees relative strength rating rise to 82 - MSN

Dec 07, 2025

Dec 06, 2025

Would You Still Hold Keros Therapeutics Stock If It Fell 30%? - Trefis

Dec 06, 2025

Dec 05, 2025

Can Keros Therapeutics Stock Hold Up When Markets Turn? - Trefis

Dec 05, 2025

Dec 05, 2025

Keros Therapeutics (NASDAQ:KROS) Trading Up 12%Here's Why - MarketBeat

Dec 05, 2025

Dec 05, 2025

There's No Escaping Keros Therapeutics, Inc.'s (NASDAQ:KROS) Muted Revenues Despite A 30% Share Price Rise - 富途牛牛

Dec 05, 2025

Dec 05, 2025

How Keros Therapeutics Inc. stock benefits from tech adoptionWeekly Earnings Recap & Risk Adjusted Buy/Sell Alerts - Newser

Dec 05, 2025

Dec 05, 2025

Franklin Resources Inc. Grows Stake in Keros Therapeutics, Inc. $KROS - Defense World

Dec 05, 2025

Dec 04, 2025

Will Keros Therapeutics Inc. stock outperform growth indexesBull Run & Fast Momentum Entry Tips - Newser

Dec 04, 2025

Dec 04, 2025

Top investors say Keros Therapeutics Inc (KROS) ticks everything they need - setenews.com

Dec 04, 2025

Dec 03, 2025

Keros Therapeutics, Inc. (NASDAQ:KROS) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

Dec 03, 2025

Dec 01, 2025

Understanding the Setup: (KROS) and Scalable Risk - Stock Traders Daily

Dec 01, 2025

Nov 30, 2025

TD Cowen Downgrades Keros Therapeutics (KROS) - MSN

Nov 30, 2025

Nov 29, 2025

Keros Therapeutics (KROS) Gets a Hold from Bank of America Securities - The Globe and Mail

Nov 29, 2025

Nov 29, 2025

Bank of America Increases Keros Therapeutics (NASDAQ:KROS) Price Target to $19.00 - MarketBeat

Nov 29, 2025

Nov 29, 2025

Keros Therapeutics (NASDAQ:KROS) Price Target Raised to $19.00 at Bank of America - Defense World

Nov 29, 2025

Nov 28, 2025

B of A Securities Maintains Keros Therapeutics (KROS) Neutral Recommendation - Nasdaq

Nov 28, 2025

Nov 28, 2025

How Much Upside is Left in Keros Therapeutics (KROS)? Wall Street Analysts Think 34.24% - MSN

Nov 28, 2025

Nov 27, 2025

KROS or NVZMY: Which Is the Better Value Stock Right Now? - MSN

Nov 27, 2025